R. Dehoff Et Al. , "Reduced risk of new onset diabetes in hypertensive coronary artery disease patients treated with a calcium antagonist vs a beta blocker regimen: The INternational VEraparnil/trandolapril STudy," 76th Annual Scientific Session of the American-Heart-Association , vol.108, ORLANDO, FLORIDA, pp.750, 2003
Dehoff, R. Et Al. 2003. Reduced risk of new onset diabetes in hypertensive coronary artery disease patients treated with a calcium antagonist vs a beta blocker regimen: The INternational VEraparnil/trandolapril STudy. 76th Annual Scientific Session of the American-Heart-Association , (ORLANDO, FLORIDA), 750.
Dehoff, R., Bakris, G., Cohen, J., Messerli, F., Erdine, S., Bristol, H., ... Pepine, C.(2003). Reduced risk of new onset diabetes in hypertensive coronary artery disease patients treated with a calcium antagonist vs a beta blocker regimen: The INternational VEraparnil/trandolapril STudy . 76th Annual Scientific Session of the American-Heart-Association (pp.750). ORLANDO, FLORIDA
Dehoff, RC Et Al. "Reduced risk of new onset diabetes in hypertensive coronary artery disease patients treated with a calcium antagonist vs a beta blocker regimen: The INternational VEraparnil/trandolapril STudy," 76th Annual Scientific Session of the American-Heart-Association, ORLANDO, FLORIDA, 2003
Dehoff, RC Et Al. "Reduced risk of new onset diabetes in hypertensive coronary artery disease patients treated with a calcium antagonist vs a beta blocker regimen: The INternational VEraparnil/trandolapril STudy." 76th Annual Scientific Session of the American-Heart-Association , ORLANDO, FLORIDA, pp.750, 2003
Dehoff, R. Et Al. (2003) . "Reduced risk of new onset diabetes in hypertensive coronary artery disease patients treated with a calcium antagonist vs a beta blocker regimen: The INternational VEraparnil/trandolapril STudy." 76th Annual Scientific Session of the American-Heart-Association , ORLANDO, FLORIDA, p.750.
@conferencepaper{conferencepaper, author={RC Dehoff Et Al. }, title={Reduced risk of new onset diabetes in hypertensive coronary artery disease patients treated with a calcium antagonist vs a beta blocker regimen: The INternational VEraparnil/trandolapril STudy}, congress name={76th Annual Scientific Session of the American-Heart-Association}, city={ORLANDO}, country={FLORIDA}, year={2003}, pages={750} }